1. Home
  2. PGEN vs CRSR Comparison

PGEN vs CRSR Comparison

Compare PGEN & CRSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.55

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Corsair Gaming Inc.

CRSR

Corsair Gaming Inc.

HOLD

Current Price

$8.70

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
CRSR
Founded
1998
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Manufacturing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
PGEN
CRSR
Price
$5.55
$8.70
Analyst Decision
Buy
Buy
Analyst Count
5
7
Target Price
$8.33
$8.50
AVG Volume (30 Days)
5.5M
4.3M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
87.37
EPS
N/A
0.11
Revenue
$230,981,000.00
$1,472,480,000.00
Revenue This Year
$1,115.92
N/A
Revenue Next Year
$81.04
$6.90
P/E Ratio
N/A
$78.73
Revenue Growth
N/A
11.86
52 Week Low
$1.40
$4.48
52 Week High
$5.61
$13.10

Technical Indicators

Market Signals
Indicator
PGEN
CRSR
Relative Strength Index (RSI) 74.63 50.71
Support Level $4.00 $8.18
Resistance Level N/A $13.10
Average True Range (ATR) 0.32 0.54
MACD 0.15 -0.14
Stochastic Oscillator 96.70 42.08

Price Performance

Historical Comparison
PGEN
CRSR

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About CRSR Corsair Gaming Inc.

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the United States (U.S.), Americas (excluding U.S.) , Europe and the Middle East, and the Asia Pacific, of which maximum revenue is generated from United States (U.S.).

Share on Social Networks: